Diane 35 (Malaysia)

  • West Malaysia will receive between 05/12/2022 to 08/12/2022
  • East Malaysia will receive between 09/12/2022 to 12/12/2022

*2 item(s) sold


  • Free shipping for West Malaysia if purchase is above RM100
  • Buy 3 and above and get 6% off (Can mix and match)
  • Up to 3% cash back to store credit when you leave a review when the order is completed
Buy 3 units and above, get 6% off
1-2 RM50.00
3-89 RM47.00
90+ RM45.00

  • Authentic product KKM sticker (Malaysia health ministry sticker)
  • 21 tablets
  • Purchase today and ship out the next working day

Contents:Cyproterone 2 mg and ethinylestradiol 0.035 mg

Indications/Uses: Hormonal contraceptive. Moderate to severe acne related to androgen-sensitivity (w/ or w/o seborrhoea) &/or hirsutism in women of reproductive age including patients w/ polycystic ovary syndrome. Acne after topical therapy or systemic antibiotic treatments has failed.

Dosage/Direction for Use: 1 tab daily on 1st day of menstrual cycle for 21 consecutive days followed by 7 tab-free days.

Contraindications: Breast cancer (current or recent) or other oestrogen- or progestin-dependent malignancies, undiagnosed vaginal bleeding, presence or history of hepatic tumours (benign or malignant), venous or arterial thromboembolism (VTE/ATE) (e.g. DVT, pulmonary embolism, MI, angina pectoris, stroke, TIA), severe or multiple risk factors for VTE/ATE (e.g. severe hypertension, diabetes mellitus, severe dyslipoproteinaemia, pancreatitis, major surgery with prolonged immobilisation), hereditary or acquired predisposition to VTE (e.g. protein C and S deficiency, hyperhomocytsteinaemia, antiphospholipid antibodies), presence or history of CVA, history of migraine with aura. Hepatic impairment. Pregnancy and lactation, Concomitant use with hepatitis C combination therapy containing ombitasvir/paritaprevir/ritonavir and dasabuvir.

Special Precautions:Women with CV disease-related risk factors (e.g. hypercholesterolaemia, hyperlipidaemia, diabetes mellitus with mild vascular disease), disorders of the connective tissue (e.g. SLE, rheumatoid arthritis, synovitis), diseases exacerbated by fluid retention (e.g. asthma, epilepsy), hereditary angioedema, depression, visual disturbance, history of migraine, chloasma gravidarum, jaundice, pruritus associated with cholestasis, cholelithiasis, sickle cell anaemia, porphyria, gallstone formation, haemolytic uraemic syndrome, Sydenham’s chorea, otosclerosis-related hearing loss. Smokers, obese patients. Not indicated for use prior to menarche, or in postmenopausal women. Renal impairment.